0001157523-21-000774 8-K 13 20210610 5.07 20210611 20210611 CHIMERA INVESTMENT CORP 0001409493 6798 260630461 MD 1231 8-K 34 001-33796 211011686 520 MADISON AVENUE 32ND FLOOR NEW YORK NY 10022 212-626-2300 520 MADISON AVENUE 32ND FLOOR NEW YORK NY 10022 8-K 1 a52444066.htm CHIMERA INVESTMENT CORPORATION 8-K false000140949300014094932021-06-102021-06-100001409493cim:CommonStockParValue001PerShareMember2021-06-102021-06-100001409493cim:Eight00SeriesACumulativeRedeemablePreferredStockMember2021-06-102021-06-100001409493cim:Eight00SeriesDCumulativeFixedToFloatingRateRedeemablePreferredStockMember2021-06-102021-06-100001409493cim:Seven75SeriesCCumulativeFixedToFloatingRateRedeemablePreferredStockMember2021-06-102021-06-100001409493cim:Eight00SeriesBCumulativeFixedToFloatingRateRedeemablePreferredStockMember2021-06-102021-06-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ______________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 10, 2021 CHIMERA INVESTMENT CORPORATION (Exact name of registrant as specified in its charter) Maryland 001-33796 26-0630461 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 520 Madison Avenue, 32nd Floor New York, New York 10022 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (212) 626-2300 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ? Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Name of Each Exchange on Symbol(s) Which Registered Common Stock, par value $0.01 per CIM New York Stock Exchange share 8.00% Series A Cumulative Redeemable CIM PRA New York Stock Exchange Preferred Stock 8.00% Series B Cumulative Fixed-to-Floating Rate Redeemable CIM PRB New York Stock Exchange Preferred Stock 7.75% Series C Cumulative Fixed-to-Floating Rate Redeemable CIM PRC New York Stock Exchange Preferred Stock 8.00% Series D Cumulative Fixed-to-Floating Rate Redeemable CIM PRD New York Stock Exchange Preferred Stock Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ? If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ? -------------------------------------------------------------------------------- Item 5.07. Submission of Matters to a Vote of Security Holders On June 10, 2021, the Company held its Annual Meeting for the purpose of: (i) electing two Class II directors to serve on the Board until the 2024 Annual Meeting of Stockholders; (ii) approving an amendment to the Company’s charter to declassify the Board of Directors; (iii) recommending, by a non-binding advisory vote, the Company’s executive compensation; and (iv) ratifying the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the current fiscal year. The total number of shares of common stock entitled to vote at the Annual Meeting was 230,713,880, of which 178,213,637 shares, or 77.24%, were present in person or by proxy. The final voting results for each of the proposals submitted to a vote of stockholders at the Annual Meeting are set forth below. Proposal 1. The election of two Class II directors to serve on the Board until the 2024 Annual Meeting of Stockholders. Director For Against Abstentions Broker Non-Votes Class II Debra W. Still 110,321,098 5,988,729 554,368 61,349,442 Mohit Marria 114,151,128 2,128,410 584,657 61,349,442 Based on the foregoing votes, Debra W. Still and Mohit Marria were elected as Class II directors to serve on the Board until the 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualify. Proposal 2. A vote on an amendment to the Company’s charter to declassify the Board of Directors. For Against Abstentions Broker Non-Votes 114,019,647 1,701,619 1,142,929 61,349,442 Proposal 3. A vote on a non-binding advisory resolution on the Company’s executive compensation. For Against Abstentions Broker Non-Votes 100,375,920 15,113,050 1,375,225 61,349,442 Proposal 4. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the Company for the current fiscal year. For Against Abstentions 175,185,074 1,893,213 1,135,350 Further information regarding these proposals is set forth in the Company’s definitive proxy statement on Schedule 14A filed with the SEC on April 27, 2021. -------------------------------------------------------------------------------- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Chimera Investment Corporation By: /s/ Rob Colligan Name: Rob Colligan Title: Chief Financial Officer Date: June 11, 2021